ACTIVE

LES PHARMACIES LAMBRECHTS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result270 k €+23,2 %over 1 year

Gross margin513,1 k €+18,7 %over 1 year

Equity469,1 k €+44,8 %over 1 year

Workforce2,7 ETP-3,6 %over 1 year

Identity

Source · BCE/KBO

LES PHARMACIES LAMBRECHTS is a Public limited company incorporated in 1992. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Molenbeek-Saint-Jean. It employs on average 2,7 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0448.543.638
Incorporation: 10/10/1992
Legal form: Public limited company
Registered office: Rue des Etangs Noirs 1A
1080 Molenbeek-Saint-Jean · BruxellesSee on map
Contributed capital: 72 880,70 €
Latest accounts: 31/12/2025
Average workforce: 2,7 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 47750Retail sale of cosmetic and toilet articles in specialised stores 47750Retail sale of cosmetic and toilet articles in specialised stores 52330Warehousing and support activities for transportation

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	513,1 k €	+18.7%	432,3 k €	+60.3%	269,7 k €	+23.0%	219,3 k €	+0.9%	217,4 k €
EBITDA	333,3 k €	+33.2%	250,3 k €	+84.2%	135,9 k €	+48.4%	91,5 k €	+12.8%	81,2 k €
Operating result	319,9 k €	+31.2%	243,9 k €	+103%	120,4 k €	+70.6%	70,6 k €	+24.1%	56,9 k €
Net result	270 k €	+23.2%	219,1 k €	+114%	102,3 k €	+88.6%	54,2 k €	+28.0%	42,4 k €
Balance sheet
Equity	469,1 k €	+44.8%	324,1 k €	+22.8%	264 k €	+19.1%	221,7 k €	0.0%	221,7 k €
Total assets	896,7 k €	+10.7%	809,8 k €	+36.5%	593,2 k €	+53.5%	386,4 k €	+7.4%	359,9 k €
Cash	339,4 k €	+33.8%	253,7 k €	-30.6%	365,5 k €	+114%	170,5 k €	+29.4%	131,8 k €
Debts	427,6 k €	-12.0%	485,7 k €	+47.5%	329,2 k €	+100%	164,5 k €	+18.9%	138,3 k €
Other
Workforce	2,7 ETP	-3.6%	2,8 ETP	0.0%	2,8 ETP		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 8 ended

Active mandates

LYRIK

Director · since 16 octobre 2023 · 0803.720.620

Represented by Illias Rahhaoui

Active

Ended mandates

Anita Seynhaeve

Mandate

Ended

Anita Seynhaeve

Managing director

Ended

Cécile Dethier

Mandate

Ended

Cécile Dethier

Managing director

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/07/2026	30/07/2025	29/08/2024	04/05/2023	25/04/2022	24/06/2021
General meeting	23/04/2026	24/04/2025	25/04/2024	28/04/2023	22/04/2022	23/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	23/04/2026	29/07/2026	French	PDF
Abridged model	31/12/2024	24/04/2025	30/07/2025	French	PDF
Abridged model	31/12/2023	25/04/2024	29/08/2024	French	PDF
Abridged model	31/12/2022	28/04/2023	04/05/2023	French	PDF
Abridged model	31/12/2021	22/04/2022	25/04/2022	French	PDF
Abridged model	31/12/2020	23/04/2021	24/06/2021	French	PDF
Abridged model	31/12/2019	24/04/2020	11/06/2020	French	PDF
Abridged model	31/12/2018	26/04/2019	27/05/2019	French	PDF
Abridged model	31/12/2017	27/04/2018	23/07/2018	French	PDF
Abridged model	31/12/2016	28/04/2017	11/08/2017	French	PDF
Abridged model	31/12/2015	29/04/2016	08/06/2016	French	PDF
Abridged model	31/12/2014	24/04/2015	14/08/2015	French	PDF
Abridged model	31/12/2013	25/04/2014	08/08/2014	French	PDF
Abridged model	31/12/2012	26/04/2013	09/08/2013	French	PDF
Abridged model	31/12/2011	27/04/2012	29/08/2012	French	PDF
Abridged model	31/12/2010	29/04/2011	16/08/2011	French	PDF
Abridged model	31/12/2009	10/06/2010	10/08/2010	French	PDF
Abridged model	31/12/2008	24/04/2009	23/07/2009	French	PDF
Abridged model	31/12/2007	25/04/2008	19/08/2008	French	PDF
Abridged model	31/12/2006	27/04/2007	14/08/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 8 ended

Active mandates

LYRIK

Director · since 16 octobre 2023 · 0803.720.620

Represented by Illias Rahhaoui

Active

Ended mandates

Anita Seynhaeve

Mandate

Ended

Anita Seynhaeve

Managing director

Ended

Cécile Dethier

Mandate

Ended

Cécile Dethier

Managing director

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates24/10/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates15/05/2018
DEMISSIONS, NOMINATIONS
PDF
Mandates06/06/2013
DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates15/05/2012
DEMISSIONS, NOMINATIONS
PDF
Mandates18/05/2006
DEMISSIONS, NOMINATIONS
PDF
Capital / shares09/05/2006
CAPITAL, ACTIONS - ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025270 k €↑
2024
Annual accounts 2024219,1 k €↑
2023
Annual accounts 2023102,3 k €↑
2022
Annual accounts 202254,2 k €↑
2021
Annual accounts 202142,4 k €↑
2020
Annual accounts 202033,6 k €↓
2019
Annual accounts 201965 k €↓
2018
Annual accounts 201895,2 k €↑
2017
Annual accounts 201752,5 k €↓
2016
Annual accounts 201665,6 k €↓
2015
Annual accounts 201570,9 k €↓
2014
Annual accounts 201480,1 k €↓
2013
Annual accounts 201383,2 k €↑
2012
Annual accounts 201270,2 k €↓
2011
Annual accounts 201172,7 k €↑
2010
Annual accounts 201060,2 k €↓
2009
Annual accounts 200968,1 k €↑
2008
Annual accounts 200861,4 k €↑
2007
Annual accounts 20071,6 k €↓
2006
Annual accounts 20066,5 k €
10/10/1992
IncorporationPublic limited company

LES PHARMACIES LAMBRECHTS

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline